molecular pathology 

Charles River offers molecular pathology services that include in situ hybridization (ISH), real-time PCR (rt-PCR), and quantitative PCR (Q-PCR). Our staff has a strong background in molecular biology and histopathology. This integration means we can relate gene expression to tissue histomorphology in both normal tissues and therapeutic models of disease, providing you with valuable functional genomics information. The end result is the best possible interpretation and troubleshooting of molecular-based tools applied to toxicological pathology issues.

We perform both isotopic and non-isotopic in situ hybridization for cell-specific localization of expressed genes in frozen and paraffin-embedded tissues. The detection of DNA and mRNA by in situ hybridization allows us to localize target DNA and gene expression to specific cell types in tissue sections. This enables our pathologists to assess the toxicity, efficacy, and biological function of your novel therapeutic compounds.

We provide a wide range of services in support of in situ gene expression studies, including: 

  • Procurement, embedding, and sectioning of study tissues
  • Synthesis of DNA and RNA probes (isotopic and non-isotopic)
  • Optimized hybridization
  • Histological evaluation by board-certified pathologists
  • Reporting that includes representative color photomicrographs

For more information please call:

1.877.CRIVER1
askcharlesriver@crl.com

view all

News & Events

view all
Jan 01 Charles River Releases 2009 Endoto...
Nov 19 Charles River Promotes Foster Jord...
Jan 28-Jan 29 Rome, Italy Global Challenges for Investigational Medicinal Products
Jan 11-Jan 16 San Diego, CA CHI's 8th Annual PepTalk Conference & Exhibition